Dogwood Therapeutics, Inc DWTX

1.36 (0.07) (4.90%) as of 25 Sep
Market cap
$48.6M
P/E
0.0×
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(143.45%) (90.31%) (109.66%) 248.89%

+8 more TTM periods

ROA
(40.68%) (29.47%) (38.50%) (84.81%)
ROIC
(41.22%) (26.54%) (25.57%) (29.46%)
Return on Tangible Assets
(439.16%) (227.34%) (659.52%) (440.56%)
Free Cash Flow per Share
(0.44) (0.46) (3.14) (9.44)
Free Cash Flow
(15.11) (15.52) (15.62) (18.11)
Piotroski F-Score
2.00 2.00 2.00 3.00
Other line items
Cash ROIC
(19.38%) (16.54%) (19.18%) (20.70%)
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00
Tax Rate
(0.06) 0.00 0.01 0.01
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.42 0.55 0.44 0.45
Depreciation/Fixed assets
0.00 0.00 4.25 8.17
Capex/Depreciation
— — 0.00 0.00
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.44) (0.46) (3.14) (9.44)
Capex per Share
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates